Osteopontina e IL-8, prometedores biomarcadores circulantes en la prognosis del melanoma avanzado
Su cuantificación mediante una tecnología de detección de múltiples analitos predice la supervivencia y la respuesta a las terapias dirigidas.
Su cuantificación mediante una tecnología de detección de múltiples analitos predice la supervivencia y la respuesta a las terapias dirigidas.
Introduction COPD causes high morbidity and mortality and high health costs. Thus, identifying and analyzing the distinctive and treatable traits seems useful to optimize the management of AEPOC patients. While various biomarkers have been researched, […]
Introduction A nosocomial outbreak of coronavirus disease (COVID-19) occurred in the Toda Chuo General Hospital in Toda City, Saitama Prefecture, Japan in December 2020. The purpose of this study was to compare the accuracy of […]
Background The objective of the study was to identify clinical and demographic factors predictive of hospitalization in primary healthcare patients diagnosed with suspected COVID-19 at the beginning of the pandemic. Methods A retrospective cohort study […]
Además de ofrecer potencial en el diagnóstico, su elevada expresión se asocia a mayor supervivencia y a menor resistencia a algunos fármacos oncológicos.
Un estudio identifica biomarcadores de resistencia y de respuesta al régimen basado en trifluridina y tipiracilo.
Introduction Risk stratification of patients with COVID-19 can be fundamental to support clinical decision-making and optimize resources. The objective of our study is to identify among the routinely tested clinical and analytical parameters those that […]
Introduction Vitamin D plays a fundamental role in many metabolic pathways, including those involved in cell proliferation and the immune response. Serum levels of this vitamin have been linked to melanoma risk and prognosis. This […]
Background and objective Accurate information on the incidence of melanoma by stage and a better understanding of transition between stages are important for determining the burden of disease and assessing the impact of new adjuvant […]